PharmaCielo Ltd. announced that further to its September 25, 2019 release relating to a supply agreement (the "Supply Agreement") it has received TSX Venture Exchange ("TSXV") approval of the export from Colombia of medicinal grade CBD isolate that is compliant with the 2018 Farm Bill to a distributor in the United States who had placed an order for up to $3 million under the Supply Agreement. The TSXV has approved the exportation of up to $3,000,000 of medicinal grade hemp derived CBD isolate under the Supply Agreement. Additional exportation of PharmaCielo products into the United States outside of the Supply Agreement is subject to the approval of the TSXV.